Myriant pulls plug on $125 mln IPO – Fortune


Fortune reported that Myriant has withdrawn its planned $125 million IPO. The publication said that no reasons were given. Based in Quincy, Mass., Myriant is a biochemical company. Its backers include Plainfield Asset Management and PTT Chemical International.